• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AMBOSS Gets €30 Million Series B to Share Medical Knowledge Around the World

Share:

October 8, 2019

Berlin-born AMBOSS, a knowledge platform for medical professionals, has raised a €30 M Series B to fuel its international rollout and app development. Investment firms Partech and Target Global led the round, with support from existing investors Cherry Ventures, Wellington Partners, and Holtzbrinck Digital.

Since its last funding in 2017, AMBOSS has evolved from an exam preparation tool for German medical students to a global platform for doctors, giving more than 500,000 users access to the latest medical knowledge. Institutions around the world are using AMBOSS to support doctors and medical students, including two of the largest hospital groups in Europe and more than 50 medical schools, including the New York University School of Medicine (NYU).

In addition to rolling out the platform worldwide, the medtech company will use the funds to further invest in its smart guidance application, which provides evidence-based information to help clinicians make decisions at the point of care.

Benedikt Hochkirchen, co-CEO of AMBOSS said, “Medical knowledge is exploding and it is almost impossible for doctors to quickly obtain reliable clinical information. Our mission is to connect every doctor with precise medical knowledge to provide the best possible care. This new funding will allow us to make a meaningful contribution to global health.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Omri Benayoun, General Partner at Partech commented: ”Better-structured medical knowledge is the foundation to improve healthcare. Physicians and students work in a time-constrained environment, where knowledge sources are proliferating, and are often complex to access and apply. At AMBOSS, software engineers, doctors, and scientists leverage technology to bring simplicity to medical knowledge modelling and delivery. We are impressed by the unique cutting-edge approach of AMBOSS to pioneer faster breakthroughs and are excited to partner with the visionary and passionate team, which is impacting global health positively.”

Date: October 08, 2019

Source: techeu

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Overcoming Key Hurdles in Decentralized Trials with Better EducationOvercoming Key Hurdles in Decentralized Trials with Better Education
  • Contract Manufacturing Market 2026 Insights, Trends, Outlook & Key Players Like- Thermo Fisher Scientific , Catalent, Inc, Lonza, Recipharm Ab, Vetter Pharma International GMBHContract Manufacturing Market 2026 Insights, Trends, Outlook & Key Players Like- Thermo Fisher Scientific , Catalent, Inc, Lonza, Recipharm Ab, Vetter Pharma International GMBH
  • Amedisys Completes Acquisition of Asana HospiceAmedisys Completes Acquisition of Asana Hospice
  • St. Paul Radiology and Suburban Radiologic Consultants Combine to Form Midwest RadiologySt. Paul Radiology and Suburban Radiologic Consultants Combine to Form Midwest Radiology
  • Investment Guide Buy Sell Hold Five StocksInvestment Guide Buy Sell Hold Five Stocks
  • Glaukos Corporation Completes Acquisition of DOSE Medical CorporationGlaukos Corporation Completes Acquisition of DOSE Medical Corporation
  • Curaleaf to Acquire Nevada-Based Acres Cannabis for $70 MillionCuraleaf to Acquire Nevada-Based Acres Cannabis for $70 Million
  • IBM Drives Watson AI EverywhereIBM Drives Watson AI Everywhere

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications